METTL3-m6A-YTHDF2-mediated decay of nucleobindin 1 (NUCB1) mRNA counteracts the effects of NUCB1 in halting pancreatic cancer growth and augmenting the antitumor with gemcitabine (GEM) (202). Here, YTHDF2 is linked to familial pancreatic carcinoma.